Prostate Cancer Support Group - Richmond, Va

Meeting Dates - 3rd Thurs. each month - Time 7:00 PM - No July Meeting - The Dec. date will vary - Call for details - Peter C. Moon Phd. at 804-346-4407 between 7 - 11:00 PM - Location - Ridge Baptist Church, 1515 Eastridge Road Richmond, VA 23229


Rva Prostate Cancer Support Group


Clinical Trials Page

In good faith, this website was created to furnish you with helpful information. Nevertheless, no one who contributes or posts information to this website makes any guarantee regarding the information provided. Any decisions that you make regarding your health should be made in consultation with a qualified healthcare provider.

Affiliated with Us-TOO International Prostate Cancer Education & Support Network
Home Us Too International Other Support Groups Facts and Stats Emerging Treatments Contact Us Articles Videos Links Peter's Notes Flyer

Clinical Trials

Prostate Cancer
This is a For Your Information Post.
Good Morning Us TOO Leaders,

We are working again with Flince Research Company to identify the following patients or caregivers of those who fit the below criteria. Us TOO has worked with Flince on other projects and we find that they are extremely respectful and appreciative of everyone who is involved. All participants who qualify will be compensated for their time. We only work with research companies who have the best interest of the patient in mind.

They are looking for patients or caregivers of patients who:

Have been through or are eligible for surgery, external beam radiation, brachytherapy or Currently being treated with Lupron/Casodex or similar medications.

National Telephone Interviews - Interviews will be 60 minute in length.

Interviews will be held over the phone during the middle of November - Caregivers are welcome to take part as well

All participants will receive a mailed check for $200 at the conclusion of the interview

Anyone interested can call - Jason Turner - 773 383 9090 -

New Hot Topic: Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer - Phillip Koo

Blue Earth Diagnostics’ Initial Results from FALCON Trial Show 61% of Patients with Suspected Recurrent Prostate Cancer had Treatment Plan Changed Following Fluciclovine (18F) PET/CT Scan

Click on Our Link for more information

F 18

or go to:
Sponsored by National Cancer Institute (NCI)

Prostvac (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance

This randomized phase II trial studies how well rilimogene-galvacirepvec works in preventing cancer from worsening,
growing, or spreading (progressing) in patients with prostate cancer that is found only in the prostate and has not
yet spread to other places in the body who are undergoing active surveillance. Vaccines made from a gene-modified virus
may help the body build an effective immune response to kill tumor cells and prevent prostate cancer from progressing.

Click on Our Link for more information


or go to:

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small
Cell Lung Cancer, or Prostate Cancer.

This phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating
patients with breast cancer, non-small cell lung cancer, or prostate cancer that has spread to other parts of the
body. Stereotactic body radiation therapy delivers fewer, tightly-focused, high doses of radiation therapy to all
known sites of cancer in the body while minimizing radiation exposure of surrounding normal tissue.

Click on Our Link for more information


or go to: